Literature DB >> 15020515

Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease.

A Boldt1, U Wetzel, J Lauschke, J Weigl, J Gummert, G Hindricks, H Kottkamp, S Dhein.   

Abstract

OBJECTIVE: To examine the hypothesis that major extracellular matrix (ECM) proteins are expressed differently in the left atrial tissue of patients in sinus rhythm (SR), lone atrial fibrillation (AF), and AF with underlying mitral valve disease (MVD).
DESIGN: Case-control study. PATIENTS: 118 patients with lone AF, MVD+AF, and SR. MAIN OUTCOME MEASURES: Collagen I, collagen III, and fibronectin protein expression measured by quantitative western blotting techniques and immunohistochemical methods.
RESULTS: Protein concentrations increased in patients with AF (all forms) compared with those in SR (all forms): collagen I (1.15 (0.11) v 0.45 (0.28), respectively; p = 0.002), collagen III (0.74 (0.05) v 0.46 (0.11); p = 0.002, and fibronectin (0.88 (0.06) v 0.62 (0.13); p = 0.08). Especially, collagen I was similarly enhanced in both lone AF (1.49 (0.15) and MVD+AF (1.53 (0.16) compared with SR (0.56 (0.28); both p = 0.01). Collagen III was not significantly increased in lone AF but was significantly increased in AF combined with MVD (0.84 (0.07) both compared with SR (0.46 (0.11); p = 0.01). The concentration of fibronectin was not significantly increased in lone AF and MVD+AF (both compared with SR). Furthermore, there was a similar degree of enhanced collagen expression in paroxysmal AF and chronic AF.
CONCLUSIONS: AF is associated with fibrosis. Forms of AF differ from each other in collagen III expression. However, there was no systematic difference in ECM expression between paroxysmal AF and chronic AF. Enhanced concentrations of ECM proteins may have a role in structural remodelling and the pathogenesis of AF as a result of separation of the cells by fibrotic depositions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15020515      PMCID: PMC1768173          DOI: 10.1136/hrt.2003.015347

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  30 in total

Review 1.  Pathophysiology and prevention of atrial fibrillation.

Authors:  M A Allessie; P A Boyden; A J Camm; A G Kléber; M J Lab; M J Legato; M R Rosen; P J Schwartz; P M Spooner; D R Van Wagoner ; A L Waldo
Journal:  Circulation       Date:  2001-02-06       Impact factor: 29.690

2.  Mechanistic insights into very slow conduction in branching cardiac tissue: a model study.

Authors:  J P Kucera; Y Rudy
Journal:  Circ Res       Date:  2001-10-26       Impact factor: 17.367

3.  Unravelling the extracellular matrix.

Authors:  A Shaub
Journal:  Nat Cell Biol       Date:  1999-11       Impact factor: 28.824

Review 4.  New ideas about atrial fibrillation 50 years on.

Authors:  Stanley Nattel
Journal:  Nature       Date:  2002-01-10       Impact factor: 49.962

5.  Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation.

Authors:  U Schotten; J Ausma; C Stellbrink; I Sabatschus; M Vogel; D Frechen; F Schoendube; P Hanrath; M A Allessie
Journal:  Circulation       Date:  2001-02-06       Impact factor: 29.690

6.  Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort.

Authors:  D Li; S Fareh; T K Leung; S Nattel
Journal:  Circulation       Date:  1999-07-06       Impact factor: 29.690

7.  Endothelin system in human persistent and paroxysmal atrial fibrillation.

Authors:  B J Brundel; I C Van Gelder; A E Tuinenburg; M Wietses; D J Van Veldhuisen; W H Van Gilst; H J Crijns; R H Henning
Journal:  J Cardiovasc Electrophysiol       Date:  2001-07

8.  Differences in organization between acute and chronic atrial fibrillation in dogs.

Authors:  H J Sih; D P Zipes; E J Berbari; D E Adams; J E Olgin
Journal:  J Am Coll Cardiol       Date:  2000-09       Impact factor: 24.094

Review 9.  Structural insights into the mechanical regulation of molecular recognition sites.

Authors:  V Vogel; W E Thomas; D W Craig; A Krammer; G Baneyx
Journal:  Trends Biotechnol       Date:  2001-10       Impact factor: 19.536

Review 10.  Electrical, contractile and structural remodeling during atrial fibrillation.

Authors:  Maurits Allessie; Jannie Ausma; Ulrich Schotten
Journal:  Cardiovasc Res       Date:  2002-05       Impact factor: 10.787

View more
  134 in total

1.  Evaluation of quantification methods for left arial late gadolinium enhancement based on different references in patients with atrial fibrillation.

Authors:  Sung Ho Hwang; Yu-Whan Oh; Dae In Lee; Jaemin Shim; Sang-Weon Park; Young-Hoon Kim
Journal:  Int J Cardiovasc Imaging       Date:  2014-11-04       Impact factor: 2.357

2.  Fibrosis and electrophysiological characteristics of the atrial appendage in patients with atrial fibrillation and structural heart disease.

Authors:  Thomas J van Brakel; Thomas van der Krieken; Sjoerd W Westra; Jeroen A van der Laak; Joep L Smeets; Henry A van Swieten
Journal:  J Interv Card Electrophysiol       Date:  2013-09-12       Impact factor: 1.900

3.  AGE-RAGE Stress in the Pathophysiology of Atrial Fibrillation and Its Treatment.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2019-12-09

Review 4.  Cardiac magnetic resonance for prediction of arrhythmogenic areas.

Authors:  Esra Gucuk Ipek; Saman Nazarian
Journal:  Trends Cardiovasc Med       Date:  2015-03-03       Impact factor: 6.677

5.  A simulation study of cellular hypertrophy and connexin lateralization in cardiac tissue.

Authors:  Thomas Seidel; Aida Salameh; Stefan Dhein
Journal:  Biophys J       Date:  2010-11-03       Impact factor: 4.033

6.  Regional left atrial voltage in patients with atrial fibrillation.

Authors:  Gregory M Marcus; Yanfei Yang; Paul D Varosy; Karen Ordovas; Zian H Tseng; Nitish Badhwar; Byron K Lee; Randall J Lee; Melvin M Scheinman; Jeffrey E Olgin
Journal:  Heart Rhythm       Date:  2006-10-20       Impact factor: 6.343

Review 7.  Improving cardiac gap junction communication as a new antiarrhythmic mechanism: the action of antiarrhythmic peptides.

Authors:  Stefan Dhein; Anja Hagen; Joanna Jozwiak; Anna Dietze; Jens Garbade; Markus Barten; Martin Kostelka; Friedrich-Wilhelm Mohr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-11-27       Impact factor: 3.000

Review 8.  Atrial fibrillation therapy now and in the future: drugs, biologicals, and ablation.

Authors:  Christopher E Woods; Jeffrey Olgin
Journal:  Circ Res       Date:  2014-04-25       Impact factor: 17.367

Review 9.  Cardiac fibroblasts : Active players in (atrial) electrophysiology?

Authors:  Alexander Klesen; Dorothee Jakob; Ramona Emig; Peter Kohl; Ursula Ravens; Rémi Peyronnet
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-02-01

10.  Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-β1.

Authors:  Dolkun Rahmutula; Gregory M Marcus; Emily E Wilson; Chun-Hua Ding; Yuanyuan Xiao; Agnes C Paquet; Rebecca Barbeau; Andrea J Barczak; David J Erle; Jeffrey E Olgin
Journal:  Cardiovasc Res       Date:  2013-04-23       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.